Briacell Therapeutics Corp.

Ordinary Shares International Reporting
Verified Company Profile 7/26/2016
Contact Info
  • 820 Heinz Avenue
  • Berkeley, CA 94710

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Apr 30, 2016 Quarterly Report
CIK 0001610820
Fiscal Year End 7/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: British Columbia, Canada
Year of Inc. 2006
Employees 12 a/o May 06, 2015
Company Officers/Contacts
Rahoul Sharan CEO
Gadi Levin CFO
Farrah Dean VP, Corp. Dev.
Company Directors
Dr. Saeid Babaei Chairman
Martin Schmieg
Rahoul Sharan
Dr. Charles Wiseman
Company Notes
  • Formerly=Ansell Capital Corp. until 12-2014
Service Providers
Accounting/Auditing Firm
900- 50 Burnhamthorpe Road West
Sussex Centre
Mississauga, ONT, L5B3C2

Legal Counsel
Bennett Jones LLP
3400 One First Canadian Place
Toronto, ONT, M5X 1A4

Szaferman Lakind Blumstein & Blader, PC
101 Grovers Mill Road
2nd Floor
Lawrenceville, NJ, 08648
United States

Investor Relations Firm
Not Available
BCTXF Security Details
Share Structure
Market Value1 $13,795,072 a/o Oct 26, 2016
Authorized Shares Unlimited a/o Jun 15, 2015
Outstanding Shares 84,736,315 a/o Jun 15, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 63,145,299 a/o Apr 01, 2015
Par Value No Par Value
Shareholders of Record 33 a/o Jun 15, 2015
Non US Stock Exchange Listing
BCT - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 6,826 (0%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security